PRISMA-Compliant Umbrella Review — Overview of Systematic Reviews
PRISMA-Compliant Umbrella Review of Systematic Reviews · Also known as: umbrella review with PRISMA, PRIOR-guided umbrella review, overview of reviews, PRISMA umbrella overview
A PRISMA-compliant umbrella review is a structured synthesis of existing systematic reviews and meta-analyses on a topic, conducted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines — specifically the PRIOR extension developed for umbrella reviews. By operating one level above primary research, it maps the totality of evidence, identifies convergent or contradictory findings across reviews, and quantifies evidence strength at the highest tier of the evidence hierarchy.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use a PRISMA-compliant umbrella review when a research topic is mature enough to have generated multiple systematic reviews or meta-analyses, and the goal is to map the entire evidence base, compare estimates across reviews, or produce a definitive evidence summary for clinical guideline development or policy. It is the appropriate design when decision-makers need a rapid but rigorous orientation to a field dominated by review-level evidence. Do not use it when only one or two systematic reviews exist — a standard systematic review or meta-analysis is more appropriate. It is also inappropriate for topics where primary studies predominate, where the question is exploratory or conceptual, or when qualitative evidence synthesis is the main goal (use meta-ethnography or qualitative meta-synthesis instead).
Strengths & limitations
- Operates at the highest tier of the evidence hierarchy, summarising the most robust available evidence in one place.
- PRISMA/PRIOR compliance ensures transparent, reproducible, and auditable reporting that meets journal and guideline standards.
- Explicitly handles overlapping evidence across reviews using the Corrected Covered Area index, reducing double-counting bias.
- Generates a broad map of evidence strength, gaps, and contradictions across a whole field quickly.
- AMSTAR-2 quality appraisal allows conclusions to be calibrated to the trustworthiness of underlying reviews.
- Entirely dependent on the quality of included systematic reviews; garbage-in-garbage-out applies across two levels.
- High evidence overlap (CCA above 15%) can inflate confidence in conclusions if not handled analytically.
- Cannot answer questions not addressed in existing systematic reviews; evidence gaps constrain the scope.
- Resource-intensive: requires expertise in systematic review methodology, quality appraisal, and PRISMA reporting across a large team.
Frequently asked
How is an umbrella review different from a standard systematic review?
A systematic review synthesises primary studies (RCTs, observational studies, etc.). An umbrella review synthesises existing systematic reviews and meta-analyses, operating one level higher in the evidence hierarchy. The eligibility criterion for inclusion is being a systematic review, not a primary study.
What is PRIOR and is it mandatory?
PRIOR (Preferred Reporting Items for Umbrella Reviews) is the PRISMA extension checklist published in 2022 specifically for umbrella reviews. It is not legally mandatory, but leading journals in evidence-based medicine and many funders require compliance with PRIOR for any submitted umbrella review. Following it is considered best practice.
What is the Corrected Covered Area and why does it matter?
The Corrected Covered Area (CCA) quantifies the degree to which primary studies are shared across the included systematic reviews. A high CCA (above 15%) indicates that many reviews draw on the same primary studies, so pooling their results would be misleading. The CCA should be reported and used to guide how much weight to give overlapping evidence in the synthesis.
Which quality appraisal tool should I use?
AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews, version 2) is the most widely recommended tool for appraising the methodological quality of systematic reviews included in an umbrella review. It yields an overall confidence rating and item-level assessments that map onto PRIOR reporting requirements.
Do I need to include low-quality systematic reviews?
Generally yes — excluding them introduces selection bias. The recommended approach is to include all eligible systematic reviews regardless of quality, appraise each with AMSTAR-2, report the quality distribution, and use quality ratings to calibrate confidence in conclusions (e.g., via GRADE). Sensitivity analyses excluding critically low-quality reviews can then test whether conclusions change.
Sources
- Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140. DOI: 10.1097/XEB.0000000000000055 ↗
- Fusar-Poli, P., Radua, J., & the PRISMA Umbrella Group (2022). PRIOR: Preferred Reporting Items for Umbrella Reviews. Evidence-Based Mental Health, 25(3), 92–99. link ↗
How to cite this page
ScholarGate. (2026, June 3). PRISMA-Compliant Umbrella Review of Systematic Reviews. ScholarGate. https://scholargate.app/en/scientometrics/prisma-compliant-umbrella-review
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Network Meta-AnalysisEvidence Synthesis↔ compare
- PRISMA-based reviewScientometrics↔ compare
- Scoping ReviewScientometrics↔ compare
- Systematic Literature ReviewScientometrics↔ compare
- Umbrella ReviewEvidence Synthesis↔ compare